[1]
M. Sokół-Szawłowska, “Bupropion as a drug of first choice in monotherapy and a complement to therapies that do not cause complete remissions – point of view of a practicing psychiatrist”, J EBM, vol. 16, no. 4(61), pp. 423-427, Dec. 2023.